{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:05:35Z","timestamp":1794647135585,"version":"4.9.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005743","name":"Universita Cattolica del Sacro Cuore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019189","name":"Bayer Portugal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.dld.2022.06.004","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:42:25Z","timestamp":1656463345000},"page":"1672-1680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["ADAMTS-13\/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study"],"prefix":"10.1016","volume":"54","author":[{"given":"Monica","family":"Sacco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira","family":"Tardugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Romana","family":"Ponziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Assunta","family":"Zocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Magistris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Santopaolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Pompili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8066-8849","authenticated-orcid":false,"given":"Raimondo","family":"De Cristofaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2022.06.004_bib0001","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2021.04.029","article-title":"Current knowledge and management of portal vein thrombosis in cirrhosis","volume":"75","author":"Senzolo","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2022.06.004_bib0002","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ajg.2016.498","article-title":"Changing concepts of cirrhotic coagulopathy","volume":"112","author":"Tripodi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.004_bib0003","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","article-title":"Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development","volume":"51","author":"Zocco","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2022.06.004_bib0004","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2022.06.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.06.004_bib0006","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/B978-0-12-385504-6.00003-8","article-title":"Structure and proteolytic properties of ADAMTS13, a metalloprotease involved in the pathogenesis of thrombotic microangiopathies","volume":"99","author":"Lancellotti","year":"2011","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.dld.2022.06.004_bib0007","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2005-01-0152","article-title":"Localization of ADAMTS13 to the stellate cells of human liver","volume":"106","author":"Uemura","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.dld.2022.06.004_bib0008","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1182\/blood-2009-07-231597","article-title":"Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage","volume":"114","author":"Turner","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.dld.2022.06.004_bib0009","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbrc.2003.11.111","article-title":"Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets","volume":"313","author":"Suzuki","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dld.2022.06.004_bib0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2141.2007.06694.x","article-title":"Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura","volume":"138","author":"Manea","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.dld.2022.06.004_bib0011","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2022.06.004_bib0012","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/156652410790963367","article-title":"The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure?","volume":"10","author":"Claus","year":"2010","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.dld.2022.06.004_bib0013","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/bloodadvances.2019000979","article-title":"von Willebrand factor\/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome","volume":"4","author":"Taylor","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.dld.2022.06.004_bib0014","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/hep.31507","article-title":"VWF\/ADAMTS13 imbalance, but not global coagulation or fibrinolysis, is associated with outcome and bleeding in acute liver failure","volume":"73","author":"Driever","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2022.06.004_bib0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1872-034X.2011.00950.x","article-title":"ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the child-turcotte-pugh score and the model for end-stage liver disease score","volume":"42","author":"Takaya","year":"2012","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2022.06.004_bib0016","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1538-7836.2008.02989.x","article-title":"Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells","volume":"6","author":"Cao","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.dld.2022.06.004_bib0017","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.25806","article-title":"von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis","volume":"56","author":"Ferlitsch","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2022.06.004_bib0018","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jhep.2016.09.025","article-title":"Procoagulant imbalance in patients with non-alcoholic fatty liver disease","volume":"66","author":"Tripodi","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2022.06.004_bib0019","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","article-title":"Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis","volume":"40","author":"Amitrano","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2022.06.004_bib0020","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/jth.12967","article-title":"Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count","volume":"13","author":"Lancellotti","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.dld.2022.06.004_bib0021","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0038-1646299","article-title":"Hereditary protein C-deficiency: laboratory values in transmitters and guidelines for the diagnostic procedure. Report on a study of the SSC subcommittee on protein C and protein S. protein C transmitter study group","volume":"68","author":"Pabinger","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.dld.2022.06.004_bib0022","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/rth2.12315","article-title":"Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia","volume":"4","author":"Sacco","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.dld.2022.06.004_bib0023","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2007-05-093021","article-title":"Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress","volume":"111","author":"Shim","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.dld.2022.06.004_bib0024","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MBC.0000000000000065","article-title":"Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis","volume":"25","author":"Stockschlaeder","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.dld.2022.06.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211010969","article-title":"No association of homocysteine, anticardiolipin antibody, and anti-beta2 glycoprotein I antibody with portal venous system thrombosis in liver cirrhosis","volume":"27","author":"Wang","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.dld.2022.06.004_bib0026","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1111\/j.1572-0241.2006.00874.x","article-title":"Platelet count\/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study","volume":"101","author":"Giannini","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.004_bib0027","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2022.06.004_bib0028","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1538-7836.2011.04429.x","article-title":"Hypercoagulability in cirrhosis: causes and consequences","volume":"9","author":"Tripodi","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.dld.2022.06.004_bib0029","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0040-1715473","article-title":"New insights into the pathogenesis, risk factors, and treatment of portal vein thrombosis in patients with cirrhosis","volume":"46","author":"Nicoara-Farcau","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.dld.2022.06.004_bib0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jhep.2013.03.036","article-title":"Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis","volume":"59","author":"Tripodi","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2022.06.004_bib0031","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/0016-5085(91)90092-Y","article-title":"A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis","volume":"101","author":"Leebeek","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.06.004_bib0032","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1160\/TH03-05-0310","article-title":"Factor VIII expression in liver disease","volume":"91","author":"Hollestelle","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.dld.2022.06.004_bib0033","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2141.2007.06688.x","article-title":"ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis","volume":"138","author":"Feys","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.dld.2022.06.004_bib0034","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11739-016-1467-x","article-title":"Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study","volume":"11","author":"Lancellotti","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.dld.2022.06.004_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2022.06.004_bib0036","article-title":"Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus","author":"Driever","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2022.06.004_bib0037","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mvr.2012.05.004","article-title":"ADAMTS13 promotes angiogenesis and modulates VEGF-induced angiogenesis","volume":"84","author":"Lee","year":"2012","journal-title":"Microvasc Res"},{"key":"10.1016\/j.dld.2022.06.004_bib0038","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mva.2003.63","article-title":"Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies","volume":"37","author":"Qin","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.dld.2022.06.004_bib0039","article-title":"The VWF\/LRP4\/alphaVbeta3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells","author":"Lagrange","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.dld.2022.06.004_bib0040","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1177\/1076029616655615","article-title":"Association of the von Willebrand factor-ADAMTS13 ratio with incident cardiovascular events in patients with peripheral arterial disease","volume":"23","author":"Green","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.dld.2022.06.004_bib0041","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MBC.0000000000000998","article-title":"Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study","volume":"32","author":"De Cristofaro","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.dld.2022.06.004_bib0042","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.amjcard.2007.03.095","article-title":"Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction","volume":"100","author":"Matsukawa","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.dld.2022.06.004_bib0043","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1160\/TH08-01-0006","article-title":"Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis","volume":"99","author":"Uemura","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.dld.2022.06.004_bib0044","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archsurg.2012.998","article-title":"Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy","volume":"147","author":"Kobayashi","year":"2012","journal-title":"Arch Surg"},{"key":"10.1016\/j.dld.2022.06.004_bib0045","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1529\/biophysj.108.131532","article-title":"Mechanistic studies on ADAMTS13 catalysis","volume":"95","author":"Di Stasio","year":"2008","journal-title":"Biophys J"},{"key":"10.1016\/j.dld.2022.06.004_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2022.03.009","article-title":"Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death","author":"Zanetto","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2022.06.004_bib0047","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1055\/s-0037-1616143","article-title":"Tissue distribution of factor VIII gene expression in vivo\u2013a closer look","volume":"86","author":"Hollestelle","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.dld.2022.06.004_bib0048","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/alcalc\/28.Supplement_1B.77","article-title":"Studies on capillarization of the hepatic sinusoids in alcoholic liver disease","volume":"1B","author":"Urashima","year":"1993","journal-title":"Alcohol Alcohol Suppl"},{"key":"10.1016\/j.dld.2022.06.004_bib0049","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejim.2014.12.002","article-title":"Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies","volume":"26","author":"Qi","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.dld.2022.06.004_bib0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.dld.2022.06.004_bib0051","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/jth.15312","article-title":"Targeting von Willebrand factor in liver diseases: a novel therapeutic strategy?","volume":"19","author":"Groeneveld","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.dld.2022.06.004_bib0052","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2022.06.004_bib0053","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.23762","article-title":"Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice","volume":"73","author":"Wang","year":"2013","journal-title":"Ann Neurol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822005436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822005436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:20:09Z","timestamp":1761625209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865822005436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1590865822005436"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2022.06.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAMTS-13\/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2022.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}